Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 2
2011 2
2012 1
2014 1
2015 1
2016 1
2017 3
2020 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma.
Kesari S, Wagle N, Carrillo JA, Sharma A, Nguyen M, Truong J, Gill JM, Nersesian R, Nomura N, Rahbarlayegh E, Barkhoudarian G, Sivakumar W, Kelly DF, Krauss H, Bustos MA, Hoon DSB, Anker L, Singh AS, Sankhala KK, Juarez TM. Kesari S, et al. Among authors: sankhala kk. Clin Cancer Res. 2024 Jan 17;30(2):323-333. doi: 10.1158/1078-0432.CCR-23-2317. Clin Cancer Res. 2024. PMID: 38047868
Heat shock proteins: a potential anticancer target.
Sankhala KK, Mita MM, Mita AC, Takimoto CH. Sankhala KK, et al. Curr Drug Targets. 2011 Dec;12(14):2001-8. doi: 10.2174/138945011798829339. Curr Drug Targets. 2011. PMID: 21777196 Review.
Future options for imatinib mesilate-resistant tumors.
Sankhala KK, Papadopoulos KP. Sankhala KK, et al. Expert Opin Investig Drugs. 2007 Oct;16(10):1549-60. doi: 10.1517/13543784.16.10.1549. Expert Opin Investig Drugs. 2007. PMID: 17922620 Review.
Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors.
Wick A, Bähr O, Schuler M, Rohrberg K, Chawla SP, Janku F, Schiff D, Heinemann V, Narita Y, Lenz HJ, Ikeda M, Ando Y, Wick W, Steinbach JP, Burger MC, Wenger K, Lassen U, Sankhala KK, Roggia C, Genvresse I, Munhoz C, Rentzsch C, Reschke S, Langer S, Wagner M, Kaulfuss S, Cai C, Lagkadinou E, Jeffers M, Peña C, Tabatabai G. Wick A, et al. Among authors: sankhala kk. Clin Cancer Res. 2021 May 15;27(10):2723-2733. doi: 10.1158/1078-0432.CCR-20-4256. Epub 2021 Feb 23. Clin Cancer Res. 2021. PMID: 33622704 Clinical Trial.
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP. Palmerini E, et al. Among authors: sankhala kk. Eur J Cancer. 2017 May;76:118-124. doi: 10.1016/j.ejca.2017.01.028. Epub 2017 Mar 17. Eur J Cancer. 2017. PMID: 28324746
14 results